The adverse drug effects of dapsone therapy in leprosy: a systematic review
- 1 September 2020
- journal article
- review article
- Published by Lepra in Leprosy Review
- Vol. 91 (3) , 232-243
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- A Review on Dapsone Hypersensitivity Syndrome Among Chinese Patients with an Emphasis on Preventing Adverse Drug Reactions with Genetic TestingThe American Journal of Tropical Medicine and Hygiene, 2017
- WHO Multidrug Therapy for Leprosy: Epidemiology of Default in Treatment in Agra District, Uttar Pradesh, IndiaBioMed Research International, 2015
- Mycobacterium Leprae –Host-Cell Interactions and Genetic Determinants in Leprosy: an OverviewFuture Microbiology, 2011
- The role of BCG in prevention of leprosy: a meta-analysisThe Lancet Infectious Diseases, 2006
- Another View of the Therapy of LeprosyAntimicrobial Agents and Chemotherapy, 1998
- Anti-inflammatory action of dapsone: inhibition of neutrophil adherence is associated with inhibition of chemoattractant-induced signal transductionJournal of Leukocyte Biology, 1997
- Clinical Pharmacokinetic Considerations in the Treatment of Patients with LeprosyClinical Pharmacokinetics, 1989
- The Story of Sulfones in Tropical Medicine and DermatologyInternational Journal of Dermatology, 1989
- Reduction of Neutrophil-mediated Injury to Pulmonary Endothelial Cells by DapsoneAmerican Review of Respiratory Disease, 1985
- TWO-AND-A-HALF YEARS' EXPERIMENTAL WORK ON THE SULPHONE GROUP OF DRUGSLeprosy Review, 1949